Riskpilot← Back to searchSign inGet full accessPX3 DIAGNOSTICS AS
ASActiveOrg 998461553Slyngveien 6A, 0376 OsloResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20121 employeeswww.px3diagnostics.com
Revenue 2024
NOK 554K
+98% vs 2023
EBITDA margin
79.5%
+183% vs 2023
Equity ratio
46.3%
Financial strength
Net profit 2024
NOK 369K
+118% vs 2023
| Revenue | NOK 554K | +98% |
| EBITDA | NOK 440K | +183% |
| Net profit | NOK 369K | +118% |
| Total assets | NOK 772K | +195% |
| Equity | NOK 358K | +3107% |
| Employees | 1 | — |
Legal name
PX3 DIAGNOSTICS AS
Org number
998461553
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
20. juni 2012
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg. Styrets leder alene.
Company purpose
Utvikling og salg av tjenester og laboratorietester og tilhørende virksomhet innen områdene diagnostikk og forebyggende helse, herunder å eie, samt direkte og indirekte deltakelse i selskaper med lignende eller annet formål.
Address
Slyngveien 6A, 0376 Oslo
Website
www.px3diagnostics.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 125 | 39 | 38 | 188 | 1 448 | 1 395 | 683 | 138 | 70 | 265 | 280 | 554 |
| Staff expenses | −0 | −354 | −0 | −0 | −0 | −913 | −960 | −270 | −0 | −0 | −0 | −59 | −57 |
| EBITDA | −189 | −425 | 3 | 0 | 87 | 174 | 127 | −24 | −84 | −34 | 110 | 156 | 440 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −189 | −425 | 3 | 0 | 87 | 174 | 127 | −24 | −84 | −34 | 110 | 156 | 440 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −0 | 0 | 0 | 14 | 11 |
| Profit before tax | −189 | −425 | 3 | 0 | 87 | 175 | 127 | −24 | −84 | −34 | 110 | 170 | 451 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | 82 |
| Net profit | −189 | −425 | 3 | 0 | 87 | 175 | 127 | −24 | −84 | −34 | 110 | 170 | 369 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 61 | 14 | 9 | 4 | 17 | 88 | 462 | 431 | 238 | 217 | 237 | 262 | 772 |
| Equity | −159 | −584 | −584 | −584 | −496 | −322 | −195 | −218 | −258 | −292 | −182 | −12 | 358 |
| Long-term debt | 0 | 0 | 0 | 588 | 0 | 0 | 0 | 0 | 0 | 0 | 419 | 242 | 72 |
| Short-term debt | 220 | 598 | 593 | 0 | 514 | 410 | 658 | 649 | 495 | 509 | 0 | 31 | 342 |
| Total debt | 220 | 598 | 593 | 588 | 514 | 410 | 658 | 649 | 495 | 509 | 419 | 274 | 414 |
EBITDA margin
79.5%
This company
15.8%
Market median
+403% vs market
20122024
Equity ratio
46.3%
This company
38.2%
Market median
+21% vs market
20122024
Return on equity
103.3%
This company
18.4%
Market median
+461% vs market
20122024
Net profit margin
66.7%
This company
8.1%
Market median
+723% vs market
20122024
Asset turnover
0.72×
This company
1.12×
Market median
-36% vs market
20122024
Debt / equity
1.16×
This company
0.62×
Market median
-87% vs market
20122024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-05-22 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BO Deputy Member | Deputy Member | 2012 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2012 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PX3 DIAGNOSTICS AS 
NAALOS HOLDING ASBoard members of PX3 DIAGNOSTICS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Brit Oppedal | Deputy Member | 0 companies |
| Ove Vincent Solesvik | Chairman | 0 companies |